On August 25, 2024, VisualDx released new images and clinical content to its subscribers. Want to start your free 7-day trial? Click here.
Some highlights:
- Mpox updates: Reflecting the current outbreak in the Democratic Republic of Congo and the WHO’s declaration of a global public health emergency.
- Hidradenitis suppurative images: 42 new images showcasing a wide variety of body locations, ages, and stages of progression, from very early to advanced stages.
- New finding: TNF-alpha inhibitor: These drugs, used to stop inflammation and treat inflammatory conditions like psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, inflammatory bowel disease (Crohn disease and ulcerative colitis), and ankylosing spondylitis, can cause various drug reactions, including acne, AGEP, adverse cutaneous reactions to targeted biologic therapies, anti-TNF-alpha-induced eruptions, and more.
- Post-COVID conditions update: Now includes the 2024 National Academies of Sciences, Engineering, and Medicine definition of long COVID.
- New patient handout for ACL injury: Patient handouts are available for hundreds of diagnoses, offering clear, concise, and reliable information about diagnoses and treatment plans to enhance patient understanding and adherence.
4,256
Total Findings
21 New Added
3,664
Total Diagnoses
11 New Added
48,508
Total Images
439 New Added
NEW Diagnoses
DERMATOLOGY
DRUG REACTIONS
- Drug-induced agranulocytosis
- Drug-induced oral mucositis
- Drug-induced peripheral edema
- Drug-induced urinary retention
EMERGENCY MEDICINE
INFECTIOUS DISEASE
ORTHOPEDICS
UROLOGY